iNCOVACC

iNCOVACC is an intranasal vaccine.

• An intranasal vaccine stimulates a broad immune response – neutralizing IgG, mucosal IgA, and T cell responses.
• Immune responses at the site of infection (in the nasal mucosa) – essential for blocking both infection and transmission of COVID-19.
• The nasal route has excellent potential for vaccination due to the organized immune systems of the nasal mucosa.

It has following advantage –

• Non-invasive, Needle-free.
• Ease of administration – does not require trained health care workers.
• Elimination of needle-associated risks (injuries and infections).
• High compliance.
• Scalable manufacturing – able to meet global ....